Bruno Pougault/LinkedIn
Oct 5, 2026, 12:51
Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA ABX SAS, shared a post on LinkedIn:
“New episode out now on Hemostasis Pulse! Is your Anti-Xa assay giving you the true physiological picture of your patient?
In this new episode, we explore the critical importance of Anti-Xa reagent selection and pre-analytical rigor for heparin monitoring (UFH amp; LMWH), fully grounded in guidelines from learned societies (ISTH, BSH, SFH, SFTH, and ASH).
What you will learn in this episode:
- Why traditional aPTT falls short due to acute-phase reactants and lupus anticoagulant interferences.
- The Dextran Sulfate Trap: How certain Anti-Xa reagents artificially overestimate residual heparin after protamine reversal in cardiac and vascular surgery.
- Pre-analytical vigilance: The crucial 60-minute centrifugation window to prevent Platelet Factor 4 (PF4) release and heparin neutralization.
- Analytical excellence: The power of two-step chromogenic assays with exogenous antithrombin. Featuring expert insights from Bruno Pougault (Global International Hemostasis Product Manager).
Listen now on Spotify.
Also streaming on Apple Podcasts on our channel Hemostasis Pulse!
How is your institution handling Anti-Xa reagent selection and pre-analytical sample turnaround?”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine